2D gel blood serum biomarkers reveal differential clinical proteomics of the neurodegenerative diseases.
about
Proteomic analysis of plasma from Portuguese patients with familial amyotrophic lateral sclerosis.The role of toxicoproteomics in assessing organ specific toxicity.Neuroproteomics as a promising tool in Parkinson's disease research.Proteomics of Alzheimer's disease: understanding mechanisms and seeking biomarkers.Alpha-synuclein and Parkinson's disease: a proteomic view.Systems biology coupled with label-free high-throughput detection as a novel approach for diagnosis of chronic obstructive pulmonary disease.Biomarkers for evaluation of clinical efficacy of multipotential neuroprotective drugs for Alzheimer's and Parkinson's diseases.Mass Spectrometry-based Proteomics and Peptidomics for Systems Biology and Biomarker Discovery.Proteomics in Parkinson's disease: current trends, translational snags and future possibilities.Peripheral biomarkers of Parkinson's disease as early reporters of central neurodegeneration.Proteomics uncovering possible key players in F508del-CFTR processing and trafficking.Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature.Biomarkers for prediction and targeted prevention of Alzheimer's and Parkinson's diseases: evaluation of drug clinical efficacy.Lymphocyte proteomics of Parkinson's disease patients reveals cytoskeletal protein dysregulation and oxidative stress.Blood-based proteomics for personalized medicine: examples from neurodegenerative disease.
P2860
Q33349895-A25BA2D9-74BE-4153-8E16-999E5A595569Q33786700-EAE06752-063E-4FD2-A845-B120DA864B4BQ33821316-2768A54E-6C5F-41BC-AE81-AE317142DC23Q36787240-DD0E826E-0F73-4424-812A-C15F8D0DD468Q37157838-F06984FE-797C-4AC8-80C0-7FD4568975A1Q37182109-A5003654-5539-4EEC-9E8A-BBC62D7D6496Q37358672-9B3E9B69-39AF-4037-B79B-32F506CB2503Q37552845-FCB9BEF2-E591-4CE2-877C-4D2A5FBF17BEQ37685124-C87DC2C6-A7E4-460F-94E4-6D8D7DA283C5Q37755118-76B58AC1-DB1A-40FD-8BB6-D670FB552E8DQ37775034-58C99A73-C5CF-48A7-946F-AC1851759BFBQ37982377-B26990B6-795B-426D-B374-44941CB89F4EQ42126269-3D3A0A82-9101-4D49-922A-F3AB3523B175Q43061595-4751B843-01D0-42A9-A920-BCD53A63A32EQ53292305-5F4F757E-F239-42DD-B4A9-CE8A04EEFA87
P2860
2D gel blood serum biomarkers reveal differential clinical proteomics of the neurodegenerative diseases.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
2D gel blood serum biomarkers ...... he neurodegenerative diseases.
@ast
2D gel blood serum biomarkers ...... he neurodegenerative diseases.
@en
type
label
2D gel blood serum biomarkers ...... he neurodegenerative diseases.
@ast
2D gel blood serum biomarkers ...... he neurodegenerative diseases.
@en
prefLabel
2D gel blood serum biomarkers ...... he neurodegenerative diseases.
@ast
2D gel blood serum biomarkers ...... he neurodegenerative diseases.
@en
P2860
P356
P1476
2D gel blood serum biomarkers ...... he neurodegenerative diseases.
@en
P2093
Essam A Sheta
Ira L Goldknopf
P2860
P356
10.1586/14789450.3.1.45
P577
2006-02-01T00:00:00Z